KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-09 4:15 pm Sale |
2022-05-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 627,321 4.310% |
-840,189 (-57.25%) |
Filing |
| 2022-02-11 6:27 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,467,510 10.170% |
-78,753 (-5.09%) |
Filing |
| 2021-02-10 5:49 pm Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,263 10.880% |
48,154 (+3.21%) |
Filing |
| 2020-08-17 3:25 pm Purchase |
2020-07-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,498,109 10.540% |
28,930 (+1.97%) |
Filing |
| 2020-08-05 4:29 pm Purchase |
2020-07-31 | 13G | Anika Therapeutics, Inc. ANIK |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,469,179 10.340% |
85,851 (+6.21%) |
Filing |